CPC Outpatient Unit

The CPCs aims to establish clinically and molecularly phenotyped patient cohorts that are assessed using conventional parameters and innovative biomarkers. The results out of those studies will contribute to a better patient care.

The partners within the CPC jointly operate an outpatient unit dedicated to coordinate studies involving lung disease patients. Essential part in those studies is the clinical and molecular phenotyping of patient cohorts with different lung diseases (such as COPD, Asthma, interstitial lung disease, BPD, lung transplantation, cystic fibrosis, lung cancer). Investigations include special criteria of the clinical development of a disease, expression of biomarkers, response to therapies, or complications. The clinical and molecular phenotyping will be performed in the specialized clinics at the Munich University Hospital or the Asklepios Fachkliniken. The clinicians are collection patient biomaterials that will be analysed in the research units at the CPC and the Institute of Lung biology and disease

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Only cookies permitted that are required for the basic functionality of our websites.
Permit cookies that help us to analyse the page views and user behavior on our websites. We only use this information for improving our services.
Permit embedded content and cookies from third party providers. This setting enables the full use of our web services (e.g. displaying videos).
Please find more information in our privacy statement.

There you may also change your settings later.